Skip to content

Clsn current stock price

HomeVoorhis80109Clsn current stock price
28.12.2020

View today's stock price, news and analysis for Celsion Corp. (CLSN). Apr 6, 2020 4:00 p.m. ET EDTComprehensive quote. 98.26%. Current Vol65 Day Avg. Celsion Corporation Common Stock (CLSN) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. (NASDAQ:CLSN) ownership structure shows current positions in the company by File Date, Form, Investor, Opt, Avg Share Price, Shares, Shares Changed 10 Feb 2020 new strategy. Celsion has new safety data. Ziopharm Oncology (ZIOP) announced its plan to issue equity shares. The issue will be priced at $3.25 apiece, significantly lower than the current market price of the stock.

CLSN - Research and Analysis for CELSION CORPORATION - MSN ...

View Celsion Corporation CLSN investment & stock information. Get the latest Celsion Corporation CLSN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Current Qtr Est, -0.17. Current Yr Est, -0.56. Exp Earnings  1 Year % Chg -64.1. Market Cap 25.9M. Shares Outstanding 29.3M. Beta 1.65. Dividend (Yield) -. Div Amount -. Ex Div Date -. Earnings Date 2020-05-13. 23 Mar 2020 Real-time trade and investing ideas on Celsion Corp. CLSN from the largest community of traders and investors. The all-time high Celsion stock closing price was 8826.30 on March 02, 2000. The Celsion 52-week high stock price is 2.42, which is 171.9% above the current   Feb 28, 2020, Celsion Corporation Prices $4.8 Million  Celsion is a biopharmaceutical company which develops innovative, targeted therapies that IPO Status Public Stock Symbol NASDAQ:CLSN Company Type For Profit Celsion has 3 current team members, including Senior Vice President,  View today's stock price, news and analysis for Celsion Corp. (CLSN). Apr 6, 2020 4:00 p.m. ET EDTComprehensive quote. 98.26%. Current Vol65 Day Avg.

Find the latest Financials data for Celsion Corporation Common Stock (CLSN) at Nasdaq.com.

Celsion (CLSN) Stock Price History | wallmine

CLSN Stock News - Fidelity

Celsion Corporation (CLSN) Stock Message Board - InvestorsHub Mar 05, 2020 · Celsion is now funding branded oncology drug development through a fastest-path-to-commercialization strategy for ThermoDox ®, its proprietary thermally sensitive liposomal encapsulation of doxorubicin.We are also identifying opportunities to expand our range of therapeutic indications through investments in our core technology platform. CLSN Stock News and Price / Celsion Corp. - Stock Price ... CLSN / Celsion Corp. 424B3 - Prospectus - 12-06 sec.gov - 8 Filed pursuant to 424(b)(3) Registration No. 333-234603 4,500,000 Shares Common Stock This prospectus relates to the sale of up to 4,500,000 shares of our common stock by Aspire Capital Fund, LLC. Should You Buy Celsion Corporation (CLSN)’s Stock Price ... Jan 24, 2020 · Celsion Corporation (NASDAQ:CLSN) is one of the worst performers on the stock market today. At current price of $1.56, the shares have already lost -0.05 points ( …

Real time Celsion (CLSN) stock price quote, stock graph, news & analysis.

View a financial market summary for CLSN including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CLSN (Celsion) stock. CLSN - Celsion Corporation Summary, Stock Quote ... - Benzinga Jan 01, 2010 · Celsion Corporation (NASDAQ: CLSN) stock research, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers on CLSN-GB: Calisen PLC - Stock Price, Quote and News - CNBC Get Calisen PLC (CLSN-GB:London Stock Exchange) real-time stock quotes, news and financial information from CNBC. Use My Current Location (Scroll for more options) CLSN Stock News - Fidelity Apr 01, 2020 · Celsion Corporation (CLSN), today announced it has entered into securities purchase agreements with institutional investors for the purchase and sale of 4,571,428 shares of the Company s common stock, par value $0.01 per share, pursuant to a registered direct offering. The Company intends to use the net proceeds from the offering for working